ANI Pharmaceuticals Inc (ANIP) stock
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3046% below fair value
$71.47+1.48 (+2.11%)
Close on Nov 18, 2026Market cap $1.64BP/E 15.2Yield –
ANI Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
ANI Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was $189.47M, up 36.2% year over year. For fiscal 2025 it was $185.23M, up 189.3% from the year before. Over ten years it grew 26.8% a year on average. The highest annual figure on record is $185.23M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $185.23M | +189.3% |
| FY2024 | Dec 31, 2024 | $64.02M | -46.2% |
| FY2023 | Dec 31, 2023 | $118.96M | – |
| FY2022 | Dec 31, 2022 | -$31.20M | -1039.3% |
| FY2021 | Dec 31, 2021 | $3.32M | -78.2% |
| FY2020 | Dec 31, 2020 | $15.27M | -66.5% |
| FY2019 | Dec 31, 2019 | $45.63M | -32.0% |
| FY2018 | Dec 31, 2018 | $67.07M | +70.2% |
| FY2017 | Dec 31, 2017 | $39.42M | +43.5% |
| FY2016 | Dec 31, 2016 | $27.47M | +59.1% |
| FY2015 | Dec 31, 2015 | $17.26M | -21.6% |
| FY2014 | Dec 31, 2014 | $22.03M | – |
| FY2013 | Dec 31, 2013 | -$5.48M | – |
| FY2012 | Dec 31, 2012 | -$137.00K | – |
| FY2011 | Dec 31, 2011 | -$47.87M | – |
| FY2010 | Dec 31, 2010 | -$40.10M | – |
| FY2009 | Dec 31, 2009 | -$18.43M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $56.67M | -25.3% |
| Q1 FY2026 | Mar 31, 2026 | $58.38M | +66.8% |
| Q4 FY2025 | Dec 31, 2025 | $30.37M | +91.5% |
| Q3 FY2025 | Sep 30, 2025 | $44.06M | +253.2% |
| Q2 FY2025 | Jun 30, 2025 | $75.81M | +335.4% |
| Q1 FY2025 | Mar 31, 2025 | $34.99M | +91.5% |
| Q4 FY2024 | Dec 31, 2024 | $15.86M | -64.6% |
| Q3 FY2024 | Sep 30, 2024 | $12.47M | -61.2% |
| Q2 FY2024 | Jun 30, 2024 | $17.41M | -15.6% |
| Q1 FY2024 | Mar 31, 2024 | $18.27M | -14.7% |
| Q4 FY2023 | Dec 31, 2023 | $44.74M | – |
| Q3 FY2023 | Sep 30, 2023 | $32.17M | +787.9% |
| Q2 FY2023 | Jun 30, 2023 | $20.63M | – |
| Q1 FY2023 | Mar 31, 2023 | $21.42M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.40M | – |
| Q3 FY2022 | Sep 30, 2022 | $3.62M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.48M | -4865.1% |
| Q1 FY2022 | Mar 31, 2022 | -$18.94M | -191.6% |
| Q4 FY2021 | Dec 31, 2021 | -$12.19M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.40M | – |
| Q2 FY2021 | Jun 30, 2021 | $241.00K | -98.8% |
| Q1 FY2021 | Mar 31, 2021 | $20.67M | +1108.7% |
| Q4 FY2020 | Dec 31, 2020 | -$5.71M | -218.9% |
| Q3 FY2020 | Sep 30, 2020 | -$1.61M | -107.4% |
| Q2 FY2020 | Jun 30, 2020 | $20.88M | +340.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.71M | -88.0% |
| Q4 FY2019 | Dec 31, 2019 | $4.80M | -82.4% |
| Q3 FY2019 | Sep 30, 2019 | $21.79M | +162.0% |
| Q2 FY2019 | Jun 30, 2019 | $4.74M | -44.8% |
| Q1 FY2019 | Mar 31, 2019 | $14.29M | -37.7% |
| Q4 FY2018 | Dec 31, 2018 | $27.23M | +72.3% |
| Q3 FY2018 | Sep 30, 2018 | $8.32M | -51.3% |
| Q2 FY2018 | Jun 30, 2018 | $8.59M | +859200.0% |
| Q1 FY2018 | Mar 31, 2018 | $22.93M | +251.2% |
| Q4 FY2017 | Dec 31, 2017 | $15.81M | +30.8% |
| Q3 FY2017 | Sep 30, 2017 | $17.08M | +1476.0% |
| Q2 FY2017 | Jun 30, 2017 | $1.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $6.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.08M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.08M | – |
See a number that looks wrong?